Oramed Pharmaceuticals In... (ORMP)
2.24
-0.03 (-1.32%)
At close: Apr 15, 2025, 3:59 PM
2.23
-0.22%
Pre-market: Apr 16, 2025, 07:14 AM EDT
13F Institute Ownership
Total Institutes of 60 in Oramed Pharmaceuticals expanded their positions with an increase of 3 investors compared to the previous quarter. An additional 713.04K shares, as total invested capital grew by $2.54M with ownership percentage increasing from 17.02% to 18.76%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.121
1.12
Call Flow 17,400
47%
Put Flow 19,500
53%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Bml Capital Management, LLC | 6.46% | 2.64M | +20.94% | 6.4M | 3.97% |
| Murchinson Ltd. | 4.28% | 1.75M | +2.46% | 4.24M | 1.81% |
| Boothbay Fund Management, LLC | 2.07% | 845.19K | +2.04% | 2.05M | 0.05% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.